Drug Profile
Tadalafil/tamsulosin - Chong Kun Dang
Alternative Names: CKD-397; Tamsulosin/tadalafilLatest Information Update: 29 Sep 2020
Price :
$50
*
At a glance
- Originator Chong Kun Dang
- Class Amines; Benzene derivatives; Benzodioxoles; Carbolines; Erectile dysfunction therapies; Ethers; Indoles; Pyridones; Small molecules; Sulfonamides; Vasodilators
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Benign prostatic hyperplasia; Erectile dysfunction
Most Recent Events
- 29 Sep 2020 Discontinued - Phase-I for Erectile dysfunction (In volunteers) in South Korea (PO) (Chong Kun Dang pipeline, September 2020)
- 29 Sep 2020 Discontinued - Phase-III for Benign prostatic hyperplasia in South Korea (PO) (Chong Kun Dang pipeline, September 2020)
- 29 Jan 2019 Chemical structure information added